Diclofenac (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Diclofenac" in Italian language version.

refsWebsite

Global rank Italian rank

40nih.gov

4^th place

9^th place

6archive.org

6^th place

8^th place

3doi.org

2^nd place

7^th place

2oadoi.org

799^th place

22^nd place

1codifa.it

low place

3,989^th place

archive.org

AS. Chandanwale, Efficacy and safety profile of combination of tramadol-diclofenac versus tramadol-paracetamol in patients with acute musculoskeletal conditions, postoperative pain, and acute flare of osteoarthritis and rheumatoid arthritis: a Phase III, 5-day open-label study., in Journal of Pain Research, vol. 12, n. 7, Aug 2014, pp. 455-63, PMID 25152629.
G. Anselmo, F. Cascio; N. Trombetta, [Comparative study of the efficacy of diclofenac sodium and indomethacin in post-operative inflammation following varicose vein surgery]., in Minerva Cardioangiol, vol. 27, n. 3, Mar 1979, pp. 153-8, PMID 379691.
JE. Wolf, JR. Taylor; E. Tschen; S. Kang, Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses., in Int J Dermatol, vol. 40, n. 11, Nov 2001, pp. 709-13, PMID 11737438.
AT. Banks, HJ. Zimmerman; KG. Ishak; JG. Harter, Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions., in Hepatology, vol. 22, n. 3, Sep 1995, pp. 820-7, PMID 7657288.
L. Laine, L. Goldkind; SP. Curtis; LG. Connors; Z. Yanqiong; CP. Cannon, How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial., in Am J Gastroenterol, vol. 104, n. 2, Feb 2009, pp. 356-62, DOI:10.1038/ajg.2008.149, PMID 19174782.
M. Epstein, L. Vickars; H. Stein, Diclofenac induced immune thrombocytopenia., in J Rheumatol, vol. 17, n. 10, Oct 1990, pp. 1403-4, PMID 2254902.

codifa.it

Voltaren - compressa a rilascio modificato (Diclofenac Sodico), indicazioni, effetti collaterali, interazioni,..., su codifa.it. URL consultato il 15 aprile 2019.

doi.org

dx.doi.org

J. Zochling, MH. Bohl-Bühler; X. Baraliakos; E. Feldtkeller; J. Braun, Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey., in Clin Rheumatol, vol. 25, n. 6, Nov 2006, pp. 794-800, DOI:10.1007/s10067-005-0132-y, PMID 16528455.
D. Pirard, P. Vereecken; C. Mélot; M. Heenen, Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies., in Arch Dermatol Res, vol. 297, n. 5, Nov 2005, pp. 185-9, DOI:10.1007/s00403-005-0601-9, PMID 16235081.
L. Laine, L. Goldkind; SP. Curtis; LG. Connors; Z. Yanqiong; CP. Cannon, How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial., in Am J Gastroenterol, vol. 104, n. 2, Feb 2009, pp. 356-62, DOI:10.1038/ajg.2008.149, PMID 19174782.

nih.gov

ncbi.nlm.nih.gov

P. McGettigan, Henry D., Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries., in PLOS medicine, vol. 10, n. 2, Feb 2013, pp. e1001388, PMID 23424288.
T. Dürrigl, M. Vitaus; I. Pucar; M. Miko, Diclofenac sodium (Voltaren): results of a multi-centre comparative trial in adult-onset rheumatoid arthritis., in J Int Med Res, vol. 3, n. 3, 1975, pp. 139-44, PMID 162669.
EC. Ku, JM. Wasvary; WD. Cash, Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase., in Biochem Pharmacol, vol. 24, n. 5, Mar 1975, pp. 641-3, PMID 804905.
AS. Chandanwale, Efficacy and safety profile of combination of tramadol-diclofenac versus tramadol-paracetamol in patients with acute musculoskeletal conditions, postoperative pain, and acute flare of osteoarthritis and rheumatoid arthritis: a Phase III, 5-day open-label study., in Journal of Pain Research, vol. 12, n. 7, Aug 2014, pp. 455-63, PMID 25152629.
P. Derry, Single dose oral diclofenac for acute postoperative pain in adults., vol. 15, n. 2, Apr 2009, pp. CD004768, PMID 19370609.
A. Bijlsma, The long-term efficacy and tolerability of Voltaren (diclofenac sodium) and indomethacin in rheumatoid arthritis., in Scand J Rheumatol Suppl, n. 22, 1978, pp. 74-80, PMID 356250.
A. Kajander, J. Martio, Diclofenac sodium (Voltaren) and naproxen in the treatment of rheumatoid arthritis: a comparative double-blind study., in Scand J Rheumatol Suppl, n. 22, 1978, pp. 57-62, PMID 356247.
G. Minisola, B. Dardano; L. Calderazzo; E. Avola, [Clinical efficacy of sodium diclofenac in chronic juvenile polyarthritis]., in Pediatr Med Chir, vol. 12, n. 2, pp. 169-73, PMID 2235663.
J. Haapasaari, E. Wuolijoki; H. Ylijoki, Treatment of juvenile rheumatoid arthritis with diclofenac sodium., in Scand J Rheumatol, vol. 12, n. 4, 1983, pp. 325-30, PMID 6361986.
G. Manz, M. Franke, [Diclofenac-Na in ankylosing spondylitis]., in Fortschr Med, vol. 95, n. 26, Jul 1977, pp. 1706-8, PMID 885458.
MA. Khan, Diclofenac in the treatment of ankylosing spondylitis: review of worldwide clinical experience and report of a double-blind comparison with indomethacin., in Semin Arthritis Rheum, vol. 15, 2 Suppl 1, Nov 1985, pp. 80-4, PMID 4081795.
J. Zochling, MH. Bohl-Bühler; X. Baraliakos; E. Feldtkeller; J. Braun, Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey., in Clin Rheumatol, vol. 25, n. 6, Nov 2006, pp. 794-800, DOI:10.1007/s10067-005-0132-y, PMID 16528455.
RN. Brogden, RC. Heel; GE. Pakes; TM. Speight; GS. Avery, Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin., in Drugs, vol. 20, n. 1, Jul 1980, pp. 24-48, PMID 6772422.
EJ. Valtonen, A comparative short-term trial with Voltaren (diclofenac sodium) and naproxen in soft-tissue rheumatism., in Scand J Rheumatol Suppl, n. 22, 1978, pp. 69-73, PMID 356249.
RL. Dreiser, Relief of acute low back pain with diclofenac-K 12.5 mg tablets: a flexible dose, ibuprofen 200 mg and placebo-controlled clinical trial., in International journal of clinical pharmacology and therapeutics, vol. 41, n. 9, Sep 2003, pp. 375-85, PMID 14518597.
O. Frank, The treatment of acute gouty arthritis., in Adv Exp Med Biol, 76B, 1977, pp. 288-9, PMID 855754.
TT. Cheng, HM. Lai; CK. Chiu; YC. Chem, A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis., in Clin Ther, vol. 26, n. 3, Mar 2004, pp. 399-406, PMID 15110132.
FM. Kudaeva, MS. Eliseev; VG. Barskova; VA. Nasonova, [Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac]., in Ter Arkh, vol. 79, n. 5, 2007, pp. 35-40, PMID 17672073.
JR. Vigneron, R. Thys, [Study of the anti-inflammatory and analgesic actions of diclofenac in traumatology and orthopedic surgery]., in Rev Med Liege, vol. 32, n. 1, Jan 1977, pp. 10-4, PMID 834928.
G. Anselmo, F. Cascio; N. Trombetta, [Comparative study of the efficacy of diclofenac sodium and indomethacin in post-operative inflammation following varicose vein surgery]., in Minerva Cardioangiol, vol. 27, n. 3, Mar 1979, pp. 153-8, PMID 379691.
JK. Rivers, DI. McLean, An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses., in Arch Dermatol, vol. 133, n. 10, Oct 1997, pp. 1239-42, PMID 9382562.
JE. Wolf, JR. Taylor; E. Tschen; S. Kang, Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses., in Int J Dermatol, vol. 40, n. 11, Nov 2001, pp. 709-13, PMID 11737438.
D. Pirard, P. Vereecken; C. Mélot; M. Heenen, Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies., in Arch Dermatol Res, vol. 297, n. 5, Nov 2005, pp. 185-9, DOI:10.1007/s00403-005-0601-9, PMID 16235081.
GM. Martin, E. Stockfleth, Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety., in J Drugs Dermatol, vol. 11, n. 5, maggio 2012, pp. 600-8, PMID 22527428.
M. Dewijze, [Voltaren in traumatology]., in Brux Med, vol. 57, n. 9, Sep 1977, pp. 381-6, PMID 912498.
W. Diebschlag, [Diclofenac in blunt traumatic ankle joint swelling. Volumetric monitoring in a placebo controlled double-blind trial]., in Fortschr Med, vol. 104, n. 21, Jun 1986, pp. 437-40, PMID 3525359.
I. Machtey, Diclofenac in the treatment of painful joints and traumatic tendinitis (including strains and sprains): a brief review., in Semin Arthritis Rheum, vol. 15, 2 Suppl 1, Nov 1985, pp. 87-92, PMID 4081796.
R. Altman, Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology., vol. 75, n. 8, May 2015, pp. 859-77, PMID 25963327.
HA. Blair, Diclofenac sodium injection (akis(®), dicloin (®)): a review of its use in the management of pain., in Clinical Drug Investigation, vol. 35, n. 6, Jun 2015, pp. 397-404, PMID 25989733.
WM. O'brien, Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs., in Am J Med, vol. 80, 4B, Apr 1986, pp. 70-80, PMID 3706353.
AT. Banks, HJ. Zimmerman; KG. Ishak; JG. Harter, Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions., in Hepatology, vol. 22, n. 3, Sep 1995, pp. 820-7, PMID 7657288.
L. Laine, L. Goldkind; SP. Curtis; LG. Connors; Z. Yanqiong; CP. Cannon, How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial., in Am J Gastroenterol, vol. 104, n. 2, Feb 2009, pp. 356-62, DOI:10.1038/ajg.2008.149, PMID 19174782.
RW. Sallie, T. McKenzie; WD. Reed; MF. Quinlan; KB. Shilkin, Diclofenac hepatitis., in Aust N Z J Med, vol. 21, n. 2, Apr 1991, pp. 251-5, PMID 1872757.
MR. Kramer, C. Levene; C. Hershko, Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy., in Scand J Haematol, vol. 36, n. 1, Jan 1986, pp. 118-20, PMID 3952461.
JF. de Quirós, V. Pinto; S. Hevia; R. Vigón, Immune complex-mediated haemolytic anaemia and Evans syndrome induced by diclofenac., in Vox Sang, vol. 72, n. 2, 1997, pp. 121-3, PMID 9088082.
S. Palmas, A. Sana; D. Onorato, [Effects of a new non-steroid anti-inflammatory agent (Voltaren) on blood platelets and erythrocytes with (G-6-PD) enzyme deficiency. Preliminary notes]., in Reumatismo, vol. 29, n. 2-3, pp. 180-3, PMID 616965.
S. George, AH. Rahi, Thrombocytopenia associated with diclofenac therapy., in Am J Health Syst Pharm, vol. 52, n. 4, Feb 1995, pp. 420-1, PMID 7757871.
M. Epstein, L. Vickars; H. Stein, Diclofenac induced immune thrombocytopenia., in J Rheumatol, vol. 17, n. 10, Oct 1990, pp. 1403-4, PMID 2254902.
A. Gibofsky, Low-dose SoluMatrix diclofenac : a review of safety across two Phase III studies in patients with acute and osteoarthritis pain., in Expert Opinion on Drug Safety, vol. 25, May 2015, pp. 1-13, PMID 26004029.
N. Moore, Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety., in Clinical Drug Investigation, vol. 27, n. 3, 2007, pp. 163-95, PMID 17305413.

oadoi.org

J. Zochling, MH. Bohl-Bühler; X. Baraliakos; E. Feldtkeller; J. Braun, Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey., in Clin Rheumatol, vol. 25, n. 6, Nov 2006, pp. 794-800, DOI:10.1007/s10067-005-0132-y, PMID 16528455.
D. Pirard, P. Vereecken; C. Mélot; M. Heenen, Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies., in Arch Dermatol Res, vol. 297, n. 5, Nov 2005, pp. 185-9, DOI:10.1007/s00403-005-0601-9, PMID 16235081.